Tradestie Institutional Equity Comparison Engine
SCEP vs TMED โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TMED Overall Edge
TMED Captures Institutional Edge (1โ0 Pillars ยท 1โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to T. Rowe Price Health Care ETF (TMED) driven by superior Momentum & Technical. Fundamentally, SCEP trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus TMED at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, SCEP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TMED sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
SCEP N/M vs TMED N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner
TMED
1Y -7.3% vs +9.5% ยท 52W Pos 2% vs 49%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SCEP
US Equity
SCEP
Institutional Equity
$23.19
-2.77% 1D
Market Cap
N/A
1M Return
-5.7%
1Y Return
-7.28%
Forward P/E
N/M
Unified AI Score
44.8 / 100
HOLD
Tech 33.0
Fund 50.0
Flow 50.0
Mom 60.0
TMED
NASDAQ
T. Rowe Price Health Care ETF
Institutional Equity
$32.06
-1.91% 1D
Market Cap
N/A
1M Return
-7.03%
1Y Return
+9.53%
Forward P/E
N/M
Unified AI Score
40.4 / 100
SELL
Tech 20.0
Fund 47.0
Flow 50.0
Mom 56.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SCEP -7.28%
TMED +9.53%
Spread: +15.47 pp (TMED Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SCEP TTM Op. Margin: N/A
TMED TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SCEP vs TMED. Trailing 12-month operating profitability (SCEP N/A vs TMED N/A) and valuation multiples (SCEP N/M vs TMED N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SCEP | TMED | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | N/A | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | N/A | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | N/A | N/A | Higher Margin | Tie |
| Net Profit Margin Profitability | N/A | N/A | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | N/A | N/A | Higher ROE | Tie |
| 52-Week Range Position Momentum | 2% ($23โ$26) | 49% ($28โ$37) | Stronger Trend | TMED |
| Beta / 30D Volatility Risk Regime | 0.79ฮฒ ยท 21% Vol | 0.67ฮฒ ยท 26% Vol | Lower Realized Risk | SCEP |
| Unified Institutional Score Composite Signal | 44.8 / 100 (HOLD) | 40.4 / 100 (SELL) | Higher Composite | SCEP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SCEP vs TMED Buy Guide
SCEP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
TMED
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SCEP nor TMED registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.